This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $64,817.75 contract provides planned maintenance services for QIAGEN equipment, with a period of performance through March 31, 2024. Qiagen is a major supplier of molecular diagnostics products and services to federal agencies, including the Department of Health and Human Services, Department of...
This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract, valued at $42,000.00, is for a QIAGEN SERVICE AGREEMENT with a performance period through June 30, 2026. Qiagen is an experienced federal contractor, having provided DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other products and services to support the...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The $262,007.51 contract provides a QIAGILITY service agreement, which covers equipment maintenance, reagent supply, and testing services. Qiagen has significant experience providing products and services to support federal biomedical research, public health, and...
This is a $14,288 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of Qiagen N.V. The contract has a period of performance from April 1, 2025 to March 31, 2026 for Qiagen to provide laboratory services under the IP0023 Statement of Work. No set-aside designation was used. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, and other applications. The company...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $49,060.00 firm fixed price purchase order to Qiagen, LLC, a division of the international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, for maintenance on laboratory equipment. The contract has a completion date of June 30, 2023 and was awarded on July 1, 2018. Qiagen has provided a range of goods and services to support federal...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $5,356.00 firm fixed price purchase order to Qiagen, LLC for equipment maintenance services. The award does not have a set-aside designation and is scheduled to be completed by April 18, 2025. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies that supports federal agencies in areas like biomedical research, public health, and law enforcement...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $57,348.26 firm fixed-price purchase order contract to Qiagen, LLC, a division of the international provider Qiagen N.V., for QIACUITY equipment and maintenance services. This contract does not have a set-aside designation. Qiagen has a history of providing products and services, such as DNA/RNA extraction kits, next-generation sequencing, and bioinformatics software, to support federal agencies'...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $55,000.00 firm fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. This contract has a completion date of May 21, 2024. Qiagen is a foreign-owned, for-profit manufacturer that has provided a range of products and services to support federal...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The $78,929.50 contract is for the provision of laboratory equipment to support the CDC's Division of Digital Public Health and Scientific Information Services (DDPHSIS). The award does not have a set-aside designation.
Qiagen is an experienced federal contractor, holding multiple indefinite...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $60,250.00 firm fixed price purchase order contract to Qiagen, LLC, a division of the parent company Qiagen N.V. The contract has an ultimate completion date of September 28, 2024 and was awarded on September 29, 2023. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academics. This contract does not have a set-aside designation. Qiagen has...